To view or add a comment, sign in GLP-1 doesnt just reduce calories
Semaglutide, a key component in both Ozempic and Wegovy, has received approval for two significant uses
Primary care doctors raise alarm as telehealth companies get involved in obesity drugs GLP-1 apps raise hurdles For stories on healthy living, subscribe to NPR's Health newsletter
today, and can lead to or exacerbate many other significant physical and mental health challenges, including type 2 diabetes, heart disease and depression
Strain WD, Frenkel O, James MA, Leiter LA, Rasmussen S, Rothwell PM, Sejersten Ripa M, Truelsen TC, Husain M
Doses above 2ml per injection do not produce additional fat loss because methylation pathways become saturated, and excess methionine converts to homocysteine rather than contributing to lipid metabolism